ArticleBMC gastroenterology2026
Predicting biliary complications after liver transplantation: a machine learning and nomogram-based exploratory study.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAccurate risk stratification of biliary complications (BCs) after liver transplantation (LT) remains challenging. This study aimed to develop and validate a machine learning (ML) and nomogram framework comprising a ML-based web calculator and a clinically interpretable nomogram for post-LT BCs.
methodsThis retrospective study analyzed 133 LT patients (2011-2025), randomly split into training (n = 94) and validation (n = 39) sets. Predictors were identified using Least Absolute Shrinkage and Selection Operator (LASSO) regression. Eight ML algorithms were trained with 5-fold cross-validation. Performance was evaluated using the area under the receiver operating characteristic curve (AUC), Brier score, and decision curve analysis (DCA). Additionally, SHapley Additive exPlanations (SHAP) were employed to visualize feature importance.
resultsThe cumulative incidence of BCs was 38.3%. Four independent predictors were identified: hepatocellular carcinoma (HCC) emerged as a protective factor, while intraoperative crystalloid infusion, preoperative partial hepatectomy, and antiviral therapy were risk factors. Light Gradient Boosting Machine (LightGBM) yielded the highest discrimination in the validation set (AUC 0.753), outperforming standard logistic regression (AUC 0.701). The LightGBM model exhibited satisfactory calibration (Brier score = 0.212) and clinical net benefit. The nomogram provided a static scoring tool, whereas the LightGBM-based web calculator offered precise individual risk estimation.
conclusionsAs an exploratory, proof-of-concept framework and an internal validation effort, the LightGBM-based web calculator offers exploratory but promising predictive accuracy for post-LT BCs, while the nomogram facilitates bedside decision-making through visual interpretability. This combined framework supports a transition from reactive management to proactive, risk-stratified surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.